Search Results - "Sterjev, Z"

Co-Existence of CYP2C191/2 and ABCB1c.3435 CT Genotype has a Potential Impact on Clinical Outcome in CAD Patients Treated with Clopidogrel by Nestorovska, KA, Naumovska, Z, Staninova Stojovska, M, Sterjev, Z, Dimovski, A, Suturkova, Lj

“…Clopidogrel, is a standard treatment in the prevention of major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD)…”
Get full text

Influence of potential gene polymorphisms on propofol dosage regimen in patients undergoing abdominal hysterectomy by Ivanov, E, Sterjev, Z, Budic, I, Nojkov, J, Karadzova, D, Sivevski, A

“…Propofol (2,6-diisopropylphenol) is the most common intravenous anesthetic used in modern medicine. It is postulated that individual differences in genetic…”
Get full text

Treatment in Transplant Eligible Multiple Myeloma Patients in Macedonia: Development of Cost-Effectiveness Analysis by Qerimi, V, Kapedanovska-Nestorovska, A, Sterjev, Z, Genadieva-Stavric, S, Suturkova, L

“…OBJECTIVES: We developed a decision-analytic model to study the impact of the three induction regimens: Vincristine-Adriamycin-Dexarnethasone (VAD),…”
Get full text

Impact of biosimilar medicinal products in the EU pharmaceutical market by Grozdanova, A, Ancevska Netkovska, K, Sterjev, Z, Naumovska, Z, Kapedanovska Nestorovska, A, Suturkova, L.j

“…Even though the most important conditions for market uptake of biosimilars are driven by commercial factors, still, real clinical evidence, clear regulatory…”
Get full text

Distribution of the Most Common Genetic Variants Associated with a Variable Drug Response in the Population of the Republic of Macedonia by Nestorovska, Kapedanovska A., Jakovski, K., Naumovska, Z., Bajro, Hiljadnikova M., Sterjev, Z., Eftimov, A., Geskovska, Matevska N., Suturkova, L., Dimitrovski, K., Labacevski, N., Dimovski, A. J.

“…Genetic variation in the regulation, expression and activity of genes coding for Phase I, Phase II drug metabolizing enzymes (DMEs) and drug targets, can be…”
Get full text

Pharmacogenetics and antipsychotic treatment response by Naumovska, Z, Nestorovska, A K, Filipce, A, Sterjev, Z, Brezovska, K, Dimovski, A, Suturkova, L J

“…Antipsychotic drugs are widely used in the treatment of schizophrenia and psychotic disorder. The lack of antipsychotic response and treatment-induced…”
Get more information

The Effects of the New Methodology Application on the Method of Pricing of Drugs—The Case of the Republic of Macedonia by Zareski, Rubin, Kapedanovska Nestorovska, A., Grozdanova, A., Dimitrova, B., Suturkova, L.J., Sterjev, Z.

“…Background: The introduction of a new methodology for the pricing of drugs by the Agency of Medicines of the Republic of Macedonia for the period 2012 to 2015…”
Get full text

Influence of the SCN1A IVS5N + 5 G>A Polymorphism on Therapy with Carbamazepine for Epilepsy by Sterjev, Z, Kiteva, G, Cvetkovska, E, Petrov, I, Kuzmanovski, I, Ribarska, T, Nestorovska, K, Matevska, N, Trajkovik-Jolevska, S, Dimovski, A, Suturkova, Lj

“…Carbamazepine (CBZ) blocks neuronal sodium channels in a voltage- and frequency-dependent manner, delaying the recovery of the channels from the inactivated…”
Get full text

Methylenetetrahydrofolate Reductase C677T Polymorphism and Risk of Colorectal Cancer in the Macedonian Population by Matevska, N, Josifovski, T, Kapedanovska, A, Sterjev, Z, Serafimoska, Z, Panovski, M, Jankulovski, N, Petrusevska, N, Angelovska, B, Petrusevska, G, Suturkova, L, Dimovski, A

“…Methylenetetrahydrofolate reductase (MTHFR) regulates the flow of folate groups between DNA synthesis and DNA methylation. A common C677T substitution…”
Get full text

Cyclin D1 G870A Variant is Associated with Increased Risk of Microsatellite Instability-Positive Colorectal Cancer in Young Male Patients by Josifovski, T, Matevska, N, Hiljadnikova-Bajro, M, Sterjev, Z, Kapedanovska, A, Serafimoska, Z, Despotovska, S, Petrusevska, N, Panovski, M, Suturkova, L, Dimovski, A

“…Cyclin D1 (CCND1) is a cell cycle regulatory protein, which is often over expressed in human tumors and is associated with cell proliferation and poor…”
Get full text

Co-Existence of CYP2C19 1/2 and ABCB1c .3435 CT Genotype has a Potential Impact on Clinical Outcome in CAD Patients Treated with Clopidogrel by Nestorovska, K A, Naumovska, Z, Staninova Stojovska, M, Sterjev, Z, Dimovski, A, Suturkova, Lj

“…Clopidogrel, is a standard treatment in the prevention of major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD)…”
Get full text

PCN89 - COST –EFFECTIVENESS ANALYSIS OF PERTUZUMAB AS FIRST LINE NEOADJUVANT TREATMENT OPTION FOR PATIENTS HER2 + BREAST CANCER IN REPUBLIC OF MACEDONIA by Kapedanovska Nestorovska, A., Sterjev, Z., Naumovska, Z., Dimovski, A., Grozdanova, A., Suturkova, L.

Get full text

PRM34 - Cost –Effectiveness of Obinutuzumab As Frontline Treatment For Unfit Patients With Chronic Lymphocytic Leukemia In Republic of Macedonia by Kapedanovska Nestorovska, A, Sterjev, Z, Naumovska, Z, Grozdanova, A, Dimovski, A, Suturkova, L

Get full text

Pharmacoeconomic Evaluation of Sorafenib As First-Line Treatment for Advanced Hepatocellular Carcinoma by Naumovska, Z, Kapedanovska Nestorovska, A, Grozdanova, A, Suturkova, L, Dimovski, A, Sterjev, Z

“…OBJECTIVES: Sorafenib significantly improve the overall survival of patients with advanced hepatocellular carcinoma (HCC). Conducted research aimed to assess…”
Get full text

PRM36 - Pharmacoeconomic Evaluation of Sorafenib As First-Line Treatment for Advanced Hepatocellular Carcinoma by Naumovska, Z, Kapedanovska Nestorovska, A, Grozdanova, A, Suturkova, L, Dimovski, A, Sterjev, Z

Get full text

PCN128 - Treatment in Transplant Eligible Multiple Myeloma Patients in Macedonia: Development of Cost-Effectiveness Analysis by Qerimi, V, Kapedanovska-Nestorovska, A, Sterjev, Z, Genadieva-Stavric, S, Suturkova, L

Get full text

Cost –Effectiveness of Obinutuzumab As Frontline Treatment For Unfit Patients With Chronic Lymphocytic Leukemia In Republic of Macedonia by Kapedanovska Nestorovska, A, Sterjev, Z, Naumovska, Z, Grozdanova, A, Dimovski, A, Suturkova, L

“…OBJECTIVES: According to the results from the CLL-11 trial, obinutuzumab+ chlorambucil (G-Clb) is superior to rituximab+chlorambucil (R-Clb) leading to an 13.8…”
Get full text

Evaluation of reliability and validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30, Albanian version) among breast cancer patients from Kosovo by Shuleta-Qehaja, Selvete, Sterjev, Zoran, Shuturkova, Ljubica

“…A sample of breast cancer patients (n=62 women) were interviewed for the European Organization for Research and Treatment of Cancer Quality of Life…”
Get full text

PCN188 - Subcutaneous Vs Intravenous Administration Of Trastuzumab In Her2+ Breast Cancer Patients: A Macedonian Cost-Minimization Analysis by Nestorovska, A, Naumoska, Z, Grozdanova, A, Stoleski, D, Ivanovska, A, Risteski, M, Vasev, N, Ismaili, I, Stefanovski, P, Dimovski, A, Suturkova, L, Sterjev, Z

Get full text

Subcutaneous Vs Intravenous Administration Of Trastuzumab In Her2+ Breast Cancer Patients: A Macedonian Cost-Minimization Analysis by Nestorovska, A, Naumoska, Z, Grozdanova, A, Stoleski, D, Ivanovska, A, Risteski, M, Vasev, N, Ismaili, I, Stefanovski, P, Dimovski, A, Suturkova, L, Sterjev, Z

Get full text